ALEXANDRIA, Va., July 16 -- United States Patent no. 12,668,574, issued on June 30, was assigned to Kuleon LLC (Seattle).

"7-azaindole analogs and methods of treating neurological disorders using the same" was invented by David Gilles (Tacoma, Wash.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Hallucinogenic and non-hallucinogenic serotonin receptor agonists are disclosed herein in addition to methods of making and using the same."

The patent was filed on Dec. 8, 2025, under Application No. 19/412,382.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AN...